|
Login
Directory:
Add Company
| Your company can benefit
from enhanced listings. Questions? Read our FAQ
first. |
Personalized notification service and newsletter info
| Subscribe (free) to get notified
of new additions. |
Learn more About us and about our Services
Contact us
|
Meloxicam 
|
|
First-to-market generic available EU registation dossier. Marketing Authorization to be obtained soon.
Offer available for: licensing Pharmaceutical form and dosage: 7,5-15 mg Tablets
Type:
- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)
Therapeutic target:
- Arthritis / Rheumato
Action: Anti-inflammatory and antirheumatic products - systemic (Rheumato) |
|
|
Full Description:
Meloxicam tablets dossier:
-New readily available for licensing
-Stability: 25°C: 24 months + continued, 40°C: 6 months
Availability and Market information:
Status: Registration
: 2002
Registration info: Marketing Authorization to be obtained soon.
Registration in several countries possible.
BE available
Market information
Other Market Info:
Patent Information:
Name: Mobic
Patent expiration date: 2003
Patent info: Development of pharmaceuticals which are still under patent is carried out according to EU-requirements in countries with no existing patents or with Bolar-provisions.
We deliver to all countries where the substance and its use are not protected by patents.
|
Suggestion box |
Disclaimer | Privacy
Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page Last modified: 15-Jan-2002.
|
Add
Company
Subscribe
Search
Contact
